Pages that link to "Q46551216"
Jump to navigation
Jump to search
The following pages link to Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. (Q46551216):
Displaying 50 items.
- Interventions for smoking cessation and reduction in individuals with schizophrenia (Q24200887) (← links)
- Interventions for smoking cessation and reduction in individuals with schizophrenia (Q24235017) (← links)
- Interventions for smoking cessation and reduction in individuals with schizophrenia (Q24242470) (← links)
- Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings (Q24289498) (← links)
- Cigarette Cravings, Impulsivity, and the Brain (Q26781531) (← links)
- Cognitive Dysfunction, Affective States, and Vulnerability to Nicotine Addiction: A Multifactorial Perspective (Q28071876) (← links)
- Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia (Q30435496) (← links)
- Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor (Q30453198) (← links)
- The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats (Q30455777) (← links)
- Predictors of early abstinence in smokers with schizophrenia (Q33679772) (← links)
- Clinical characteristics of heavy and non-heavy smokers with schizophrenia (Q33775576) (← links)
- Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder. (Q33811740) (← links)
- Smoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis (Q33909736) (← links)
- Higher serum caffeine in smokers with schizophrenia compared to smoking controls (Q33912741) (← links)
- Reasons for smoking among individuals with schizophrenia (Q33926975) (← links)
- Higher nicotine levels in schizophrenia compared with controls after smoking a single cigarette (Q34023532) (← links)
- Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness (Q34185669) (← links)
- Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation (Q34621879) (← links)
- Lower task persistence in smokers with schizophrenia as compared to non-psychiatric control smokers (Q34682158) (← links)
- Investigation of cigarette smoking among male schizophrenia patients (Q34970938) (← links)
- Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits (Q35048154) (← links)
- Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder (Q35196495) (← links)
- Nicotine effects in adolescence and adulthood on cognition and α₄β₂-nicotinic receptors in the neonatal ventral hippocampal lesion rat model of schizophrenia (Q35547417) (← links)
- Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices (Q35701489) (← links)
- Alpha7 Nicotinic Acetylcholine Receptors Modulate Motivation to Self-Administer Nicotine: Implications for Smoking and Schizophrenia (Q35837691) (← links)
- Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia (Q35880018) (← links)
- Rapid smoking may not be aversive in schizophrenia. (Q36471911) (← links)
- Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls (Q36471948) (← links)
- Task persistence predicts smoking cessation in smokers with and without schizophrenia (Q36708830) (← links)
- Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis (Q36711713) (← links)
- A comprehensive model for mental health tobacco recovery in new jersey. (Q36800503) (← links)
- Cigarette demand and delayed reward discounting in nicotine-dependent individuals with schizophrenia and controls: an initial study (Q36807511) (← links)
- Nicotine intake and smoking topography in smokers with bipolar disorder (Q36810188) (← links)
- Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophrenia (Q36848924) (← links)
- Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia (Q37079797) (← links)
- Smoking topography and outcome expectancies among individuals with schizotypy. (Q37141290) (← links)
- High-affinity nicotinic acetylcholine receptor expression and trafficking abnormalities in psychiatric illness (Q37154489) (← links)
- Cigarette Smoking and Health Characteristics in Individuals With Serious Mental Illness Enrolled in a Behavioral Weight Loss Trial. (Q37190653) (← links)
- Smoking behaviour and mental health disorders--mutual influences and implications for therapy (Q37295878) (← links)
- Open-Label Study of Craving in Smokers With Schizophrenia Using Nicotine Nasal Spray Compared to Nicotine Patch (Q37349098) (← links)
- Lower ß2*-nicotinic acetylcholine receptor availability in smokers with schizophrenia (Q37436125) (← links)
- Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study (Q37442261) (← links)
- Smoking expectancies and intention to quit in smokers with schizophrenia, schizoaffective disorder and non-psychiatric controls (Q37481586) (← links)
- Nicotine is more addictive, not more cognitively therapeutic in a neurodevelopmental model of schizophrenia produced by neonatal ventral hippocampal lesions (Q37565145) (← links)
- Effects of smoking abstinence on cigarette craving, nicotine withdrawal, and nicotine reinforcement in smokers with and without schizophrenia (Q37576343) (← links)
- Smoking Cessation Intervention for Severe Mental Ill Health Trial (SCIMITAR ): study protocol for a randomised controlled trial (Q37609782) (← links)
- Smoking cessation and reduction in schizophrenia (SCARIS) with e-cigarette: study protocol for a randomized control trial (Q37714728) (← links)
- A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia (Q37962995) (← links)
- A tail with a thorn in it: second-generation antipsychotics hand in hand with statins (Q38029297) (← links)
- Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation (Q38204497) (← links)